Segmed

Provides access to de-identified medical data

Palo Alto, California, United States

About Segmed

Segmed provides a platform for accessing millions of de-identified and standardized medical images and records, specifically designed for research and development in healthcare. This platform is particularly useful for artificial intelligence teams that need large amounts of diverse medical data to enhance their projects. Segmed's service allows clients, including clinical operations executives and healthcare organizations, to obtain machine-readable data quickly, often within days, which helps speed up their research timelines. Additionally, Segmed assists healthcare organizations in monetizing their unused medical data, creating a passive revenue stream while ensuring their data contributes to ongoing medical research. The company generates revenue by charging clients for access to its extensive database and by facilitating data monetization for healthcare providers.

Palo Alto, CaliforniaHeadquarters
2019Year Founded
$19.3MTotal Funding
SERIES_ACompany Stage
Data & Analytics, AI & Machine Learning, HealthcareIndustries
11-50Employees

Risks

Synthetic data generation may face challenges in accuracy and reliability.
Rebranding to Openda may disrupt customer experience and brand recognition.
Partnerships may face regulatory scrutiny due to synthetic data's novelty.

Differentiation

Segmed offers a vast repository of de-identified, standardized medical images and records.
The company provides rapid access to machine-readable data for healthcare R&D.
Segmed enables healthcare organizations to monetize untapped medical data assets.

Upsides

Segmed's partnership with Nvidia enhances AI capabilities in healthcare.
The $10.4 million Series A funding shows strong investor confidence.
Openda's launch reflects a trend towards comprehensive data solutions in healthcare.